$SBRA

24/7 Wall St. lists Thursday analyst calls. JPMorgan upgraded Charles River Laboratories (CRL) to Overweight, target $310. Wolfe raised Global Payments (GPN) to Outperform, target $110. Argus upgraded Roper Technologies (ROP) to Buy, target $450. Piper cut AppLovin (APP) to Neutral, target $385, and HubSpot (HUBS) to Neutral, target $220. Several other upgrades, downgrades, and initiations are noted.

Sabra Health Care REIT (SBRA) shares rose about 0.2% to around $20.66 after Q2 2026 results. Revenue increased to $238.09 million from $189.98 million, but net income fell to a $25.20 million loss from a $65.54 million profit. Normalized FFO was $0.38 and adjusted FFO $0.40, supporting a $0.30 dividend. The company recorded a $102.4 million loan loss provision.

Sabra Health Care REIT, Inc. (SBRA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.3 4 sbraex9932026q2.htm Q2 2026 NON-GAAP RECONCILIATIONS Document Reconciliations of Non-GAAP Financial Measures June 30, 2026 (Unaudited) SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES 2026 OUTLOOK FFO, Normalized FFO, AFFO and Normalized AFFO

The article highlights four high-yield stocks and one mortgage REIT, focusing on dividend yield, volatility (beta), and recent actions. First Interstate BancSystem (FIBK) announced a $150M buyback, totaling $450M, after repurchasing about 8%. Sabra (SBRA) raised full-year FFO/AFFO guidance after a tenant transition with ~30% higher rent. Getty Realty (GTY) and Kinetik (KNTK) are discussed, and Ellington Financial (EFC) is noted for an 11.5% yield with adjusted distributable earnings guidance of

Sabra Health Care REIT (SBRA) shares rose over 10% after the company issued an operational update. Sabra said it signed letters of intent to retenant 26 Avamere properties, targeting $53M annual rent versus $41M prior. It also arranged to retire a $300M RCA mortgage with $200M cash. Sabra raised 2026 guidance to $0.37-$0.39 headline net income and $1.59-$1.61 normalized AFFO.

Avamere plans to exit skilled nursing by ending management agreements for 26 Sabra Healthcare REIT (SBRA) properties. Sabra will reassign 22 sites to Cascadia Healthcare and four to subsidiaries of an existing tenant. Sabra set Cascadia’s closing rent at $53 million, with the deal expected to close this year, according to Sabra.

Fitch Ratings said four senior housing REITs, CareTrust (CTRE), National Health Investors (NHI), Sabra (SBRA) and Omega (OHI), earned similar “BBB-” credit ratings. Fitch cited differences in liquidity and leverage, noting a trend to reduce skilled nursing exposure and expand managed operating platforms, including RIDEA structures. It also highlighted U.K. exposure and NHI’s positive outlook factor.

The article compares senior housing REITs Sabra Health Care (SBRA) and Welltower (WELL), citing improving demand and occupancy. Sabra reported Q1 revenue of $221.7M (+20.8%) and NFFO/share of $0.38 (+8.5%), with 14.4% YoY same-store cash NOI growth. Welltower reported Q1 revenue of $2.78B (+49.1%) and NFFO/share of $1.47 (+22.5%), with NOI up 16.4% YoY.

Sabra Health Care REIT, Inc. (SBRA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. sbra-20260617 false 0001492298 0001492298 2026-06-17 2026-06-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):

Sabra Healthcare REIT (NASDAQ: SBRA) received a consensus “Moderate Buy” rating from 10 analysts, with five “hold” and five “buy” ratings, according to MarketBeat. The average 12-month target price is $22.30. Wells Fargo and UBS raised targets to $22; Citigroup to $24. SBRA reported $0.16 EPS on $211.74M revenue and paid a $0.30 quarterly dividend (6% yield).